Primary and Secondary Prevention of Pancreatic Cancer
Anqi Yu,Tiffany A. Romero,Jeanine M. Genkinger
DOI: https://doi.org/10.1007/s40471-019-00189-2
2019-05-16
Current Epidemiology Reports
Abstract:Purpose of ReviewPancreatic cancer remains one of the most lethal of malignancies with 5-year survival of only 8%. A number of reasons account for the high fatality rate including few known modifiable risk factors, no effective screening tools, and lack of early diagnostic symptoms. Therefore, in this review, we aim to summarize existing evidence from major studies concerning (1) risk factors for risk assessment and risk stratification, and (2) screening modalities and early detection markers to better understand the ways to prevent pancreatic cancer or identify it at earlier stages. Improvements in primary and secondary prevention of pancreatic cancer are critical to reduce the morbidity and mortality of this deadly disease.Recent FindingsWe searched the published literature and identified studies of pancreatic cancer risk published prior to September 30, 2018, with an emphasis on manuscripts publicized during the last 5–10 years. Known and suspected risk factors include familial and genetic risk, smoking, obesity, alcohol, poor diet including sugary sweetened beverages, diabetes, and periodontal disease. Recent advances have identified potential early detection markers (e.g., ctDNA, circulating cancer cells, metabolites, and miRNA).SummaryCurrently, pancreatic cancer has few known and suspected risk factors, and risk assessment tools have limited utility given their modest discriminatory power. Although emerging evidence suggests blood-based biomarkers may be useful as early detection markers, findings need to be confirmed in prospective studies. Due to the rarity of disease, future studies should consider a two-tiered approach in which risk assessment is used to identify high-risk individuals for screening, and then effective imaging and biomarkers in pathways known to affect pancreatic cancer risk are employed; these combination approaches may reduce false positives and mortality compared with just risk assessment or screening alone.
public, environmental & occupational health